This is the authors' abstract. We don't add key points for this paper.
SARS-CoV-2 evolution, particularly the emergence of Omicron variants, has challenged vaccine efficacy, necessitating antigens with broad and variant-specific protection. To design mRNA vaccine antigens with broad-spectrum immunity and enhanced stability, we developed two spike antigens using in silico optimization: Css_dsg S, the ancestral strain–Delta variant consensus with stabilizing mutations, and Omi_dsg S, an Omicron-adapted design. Computational analysis identified two critical N-terminal domain stabilization sites consistently enhancing protein expression across variants, suggesting their potential as universal stabilizing elements. Css_dsg S elicited robust IFN-γ T cell responses and significantly elevated neutralizing antibody titers against variants in BALB/c mice. Omi_dsg S induced strong immune responses in vivo . A bivalent mRNA vaccine combining both antigens elicited superior neutralizing antibody responses and conferred enhanced protection against BN.1 and BA.5 challenges in K18-hACE2 mice. These findings support computationally optimized spike antigens, particularly the bivalent formulation, as a promising strategy for next-generation vaccines against SARS-CoV-2 variants.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Yeo et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: